These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26096539)

  • 1. Interleukin-1 as a pharmacological target in acute brain injury.
    Brough D; Rothwell NJ; Allan SM
    Exp Physiol; 2015 Dec; 100(12):1488-94. PubMed ID: 26096539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A brain in flame; do inflammasomes and pyroptosis influence stroke pathology?
    Barrington J; Lemarchand E; Allan SM
    Brain Pathol; 2017 Mar; 27(2):205-212. PubMed ID: 27997059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AIM2 and NLRC4 inflammasomes contribute with ASC to acute brain injury independently of NLRP3.
    Denes A; Coutts G; Lénárt N; Cruickshank SM; Pelegrin P; Skinner J; Rothwell N; Allan SM; Brough D
    Proc Natl Acad Sci U S A; 2015 Mar; 112(13):4050-5. PubMed ID: 25775556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of interleukin-1 in acute brain injury.
    Brough D; Tyrrell PJ; Allan SM
    Trends Pharmacol Sci; 2011 Oct; 32(10):617-22. PubMed ID: 21788085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postnatal administration of IL-1Ra exerts neuroprotective effects following perinatal inflammation and/or hypoxic-ischemic injuries.
    Girard S; Sébire H; Brochu ME; Briota S; Sarret P; Sébire G
    Brain Behav Immun; 2012 Nov; 26(8):1331-9. PubMed ID: 22982341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-1α and brain inflammation.
    Brough D; Denes A
    IUBMB Life; 2015 May; 67(5):323-30. PubMed ID: 25906979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-37 Attenuates Lipopolysaccharide (LPS)-Induced Neonatal Acute Respiratory Distress Syndrome in Young Mice via Inhibition of Inflammation and Cell Apoptosis.
    Li B; Ji X; Tian F; Gong J; Zhang J; Liu T
    Med Sci Monit; 2020 Mar; 26():e920365. PubMed ID: 32152260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
    Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
    Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease.
    Abbate A; Toldo S; Marchetti C; Kron J; Van Tassell BW; Dinarello CA
    Circ Res; 2020 Apr; 126(9):1260-1280. PubMed ID: 32324502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-1 and neuronal injury: mechanisms, modification, and therapeutic potential.
    Rothwell N
    Brain Behav Immun; 2003 Jun; 17(3):152-7. PubMed ID: 12706413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-1 and acute brain injury.
    Murray KN; Parry-Jones AR; Allan SM
    Front Cell Neurosci; 2015; 9():18. PubMed ID: 25705177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation and regulation of cellular inflammasomes: gaps in our knowledge for central nervous system injury.
    de Rivero Vaccari JP; Dietrich WD; Keane RW
    J Cereb Blood Flow Metab; 2014 Mar; 34(3):369-75. PubMed ID: 24398940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammasomes: a novel therapeutic target in pulmonary hypertension?
    Scott TE; Kemp-Harper BK; Hobbs AJ
    Br J Pharmacol; 2019 Jun; 176(12):1880-1896. PubMed ID: 29847700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extent of Ischemic Brain Injury After Thrombotic Stroke Is Independent of the NLRP3 (NACHT, LRR and PYD Domains-Containing Protein 3) Inflammasome.
    Lemarchand E; Barrington J; Chenery A; Haley M; Coutts G; Allen JE; Allan SM; Brough D
    Stroke; 2019 May; 50(5):1232-1239. PubMed ID: 31009361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocyte-specific deletion of IL1-RI attenuates liver injury by blocking IL-1 driven autoinflammation.
    Gehrke N; Hövelmeyer N; Waisman A; Straub BK; Weinmann-Menke J; Wörns MA; Galle PR; Schattenberg JM
    J Hepatol; 2018 May; 68(5):986-995. PubMed ID: 29366909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IMM-H004 therapy for permanent focal ischemic cerebral injury via CKLF1/CCR4-mediated NLRP3 inflammasome activation.
    Ai QD; Chen C; Chu S; Zhang Z; Luo Y; Guan F; Lin M; Liu D; Wang S; Chen N
    Transl Res; 2019 Oct; 212():36-53. PubMed ID: 31176667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minocycline Protects Against NLRP3 Inflammasome-Induced Inflammation and P53-Associated Apoptosis in Early Brain Injury After Subarachnoid Hemorrhage.
    Li J; Chen J; Mo H; Chen J; Qian C; Yan F; Gu C; Hu Q; Wang L; Chen G
    Mol Neurobiol; 2016 May; 53(4):2668-78. PubMed ID: 26143258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viroporins and inflammasomes: A key to understand virus-induced inflammation.
    Farag NS; Breitinger U; Breitinger HG; El Azizi MA
    Int J Biochem Cell Biol; 2020 May; 122():105738. PubMed ID: 32156572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Inflammasomes to Treat Neurological Diseases.
    Lünemann JD; Malhotra S; Shinohara ML; Montalban X; Comabella M
    Ann Neurol; 2021 Aug; 90(2):177-188. PubMed ID: 34219266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-1 and stroke: biomarker, harbinger of damage, and therapeutic target.
    Denes A; Pinteaux E; Rothwell NJ; Allan SM
    Cerebrovasc Dis; 2011; 32(6):517-27. PubMed ID: 22104408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.